Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT06417606 · UNKNOWN
Trial details
- NCT number
- NCT06417606
- Sponsor
- Zhiyong Huang
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2025-04-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.